The cannabis industry is catching the eye of investors, and financing and growth opportunities abound. This panel will discuss the most relevant issues within this area and the best practices applied by leading practitioners in this field. The panel will provide an overview of financing opportunities and methods, timing for investments and other financing vehicles, and positioning your clients for responsible growth.
This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules.
INCBA webinars are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.
INCBA on demand programs are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted.
For current accreditation status, please select your jurisdiction below.
|Supporting News Articles (181.2 KB)||9 Pages||Available after Purchase|
|Here's How to Make Sense of the Canopy Growth, Acreage Deal (678.8 KB)||Available after Purchase|
|TIMELY DISCLOSURE, TRADING HALTS AND POSTING REQUIREMENTS (201 KB)||Available after Purchase|
|Tech-Enabled M&A Solutions for the Age of COVID-19 (179.6 KB)||2 Pages||Available after Purchase|
|Cannabis Opportunities in Distressed Markets (160.5 KB)||4 Pages||Available after Purchase|
David N. Feldman concentrates his practice on corporate and securities law and mergers and acquisitions, as well as general representation of public and private companies, entrepreneurs, investors, and private equity and venture capital firms. Mr. Feldman also advises emerging growth companies with regard to alternatives to traditional financing through initial public offerings. He is considered an authority on public offerings through SEC Regulation A+. He published a book on that subject, called Regulation A+ and Other Alternatives to a Traditional IPO (John Wiley & Sons), in 2018. Mr. Feldman also represents a wide range of clients, including entrepreneurial companies, investors, lenders, investment banking firms and other businesses, in the emerging legal cannabis industry. He provides guidance on private placements, public offerings, loan structuring and fund formation for cannabis companies, as well as corporate structuring advice and applications for grow, processing and dispensary licenses. He advises on risk assessment issues for large, multinational businesses seeking to enter the cannabis industry. He is a founding partner of Skip Intro Advisors, a cannabis-focused business consulting firm focused on strategic and financial advisory, branding, technology and license application preparation and submission. In April 2019 the global guide Chambers & Partners ranked Mr. Feldman as a leading US attorney in cannabis law and one of only seven US lawyers in “band 1” for corporate and transactional work in the industry. In addition, in October 2018 the National Law Journal named him a “Cannabis Law Trailblazer” and in January 2019 Business Insider named him as a top lawyer in the cannabis industry.
Mr. Feldman is the former team lead of an AmLaw 100 firm’s Cannabis Industry Group. He frequently speaks at industry conferences and is quoted by numerous publications about legal developments and business news in this rapidly expanding market. A graduate of the Wharton School of Business at the University of Pennsylvania as well as the University of Pennsylvania Law School, Mr. Feldman is the former chair of Wharton’s worldwide alumni association board.
Matthew Kittay is Co-Chair of Fox Rothschild’s Mergers & Acquisitions Practice Group. He is nationally recognized as an innovative leader who guides businesses, investors and entrepreneurs to achieve the corporate financing and structures that drive their success. Matthew has deep experience in structuring mergers and acquisitions and securing private equity and venture capital for a wide range of companies, particularly in the technology, software, cannabis, manufacturing and health care sectors. He serves as Outside General Counsel for emerging and growth-stage companies, advising clients on a host of regulatory and corporate matters and resolving a range of legal issues as they arise.
Matthew is ranked Band 1 by Chambers USA as a leading corporate attorney for his transactional work with clients in the cannabis sector. Following a string major deals he closed in 2019, The National Law Journal recognized him as a Trailblazer in Cannabis Law. A leader in his legal communities, he is Co-Chair of the Angel Venture Capital Subcommittee and as the M&A Technology Subcommittee's Liaison to the Legal Analytics Committee of the American Bar Association’s Business Law Section. Among his community service activities, Matthew he has served on Brown University’s Communications Advisory Committee to the President since 2017, and was awarded a Protector Pioneer Award for pro bono services at the United Nations in 2019.
Emily Paxhia is a co-founder and Managing Partner of Poseidon.
Emily has reviewed thousands of companies in the cannabis industry and has worked with countless founders in many capacities. She had helped to shape founders' pitch preparations, their go-to-market strategies/ product launches, and advised on day-to-day business operations. Emily has held board seats for multiple portfolio companies and participates as an adviser to multiple teams.
Extremely active in the investment decision making and ongoing investment oversight processes, she works closely with her partners to create meaningful deal structures, ensuring that proper governance is carried out at the company level. Further, Emily has dedicated time and energy to supporting policy groups and has served on the Board of Directors of the Marijuana Policy Project. She also currently serves on the Board of Athletes for CARE and The Initiative.
Emily has over 10 years of experience working as a consultant and researcher, and as such, has become an expert at extracting actionable insights from research and applying them to make corporations function more efficiently and successfully. She also leverages this experience to engage in detailed market analysis for determination around product-market fit and potential scalability.
Emily graduated from New York University with an M.A. in Psychology in 2008. She graduated from Skidmore College with a B.A. in Psychology in 2002.
The Changing Face of Raising Money: From Equity to Debt & Convertible Debt
Original Program Date: 10/06/2020 - SKU INCBA100620TH2
Supply Chain Dynamics
Original Program Date: 10/06/2020 - SKU INCBA100620SU
Please wait ...